Cargando…
Improvement of sleep and melatonin in children with autism spectrum disorder after β‐1,3/1,6‐glucan consumption: An open‐label prospective pilot clinical study
INTRODUCTION: Poor sleep quality is a major problem in patients with autism spectrum disorder (ASD), and is attributed to low melatonin levels. Melatonin supplementation is recommended; however, its effectiveness varies. β‐Glucans have previously been shown to improve melatonin levels in animal stud...
Autores principales: | Raghavan, Kadalraja, Dedeepiya, Vidyasagar Devaprasad, Kandaswamy, Ramesh Shankar, Balamurugan, Mangaleswaran, Ikewaki, Nobunao, Sonoda, Tohru, Kurosawa, Gene, Iwasaki, Masaru, Preethy, Senthilkumar, Abraham, Samuel JK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480952/ https://www.ncbi.nlm.nih.gov/pubmed/35993920 http://dx.doi.org/10.1002/brb3.2750 |
Ejemplares similares
-
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022) -
Benefits of Gut Microbiota Reconstitution by Beta 1,3–1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases
por: Raghavan, Kadalraja, et al.
Publicado: (2023) -
Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022) -
Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2023) -
Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
por: Raghavan, Kadalraja, et al.
Publicado: (2023)